Immune-stromal-lymphatic communication shapes the context-dependent relationship between Hashimoto thyroiditis and papillary thyroid carcinoma

Hashimoto thyroiditis (HT) and papillary thyroid carcinoma (PTC) frequently coexist, yet their clinical relationship remains paradoxical. Surgical and epidemiological series establish heterogeneous clinical associations: PTC is detected more often in some HT cohorts, whereas coexistent HT is associated with less aggressive disease in many outcome studies. Tissue studies separately establish organized autoimmune inflammation in HT and heterogeneous immune, stromal, endothelial, and lymphatic programs in PTC. What is not established is that these compartments form a single causal mechanism at the HT-PTC interface. The principal contribution of this review is therefore a hypothesis-generating, spatially explicit framework asking whether autoimmune tissue architecture that may predate tumor detection modifies subsequent tumor evolution. We distinguish distant autoimmune follicles from tumor-associated tertiary lymphoid structures (TLSs), and we separate direct HT-PTC observations from HT-only evidence, PTC evidence that is not HT-specific, and mechanistic extrapolation. The proposed framework integrates CCL21-CCR7 and CXCL13-CXCR5 signaling, ACKR1-positive endothelial entry sites, fibroblast states, TLS phenotype and location, and VEGF-C/VEGF-D-VEGFR3-associated lymphatic remodeling. These processes may have different relevance to tumor initiation and to progression after PTC is established. Depending on region, tumor genotype, immune function, stromal state, and tumor-lymphatic proximity, an inflamed gland may support epithelial injury, productive antitumor immunity, an inflamed but ineffective immune state, or lymphatic dissemination. These spatial features remain mechanistic and exploratory prognostic candidates; they are not validated diagnostic, predictive, or treatment-directing biomarkers. Region-matched human studies, functional perturbation, independent retrospective validation, and prospective clinical-utility testing are required.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-12
DOI
https://doi.org/10.3389/fimmu.2026.1958121
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immune-stromal-lymphatic communication shapes the context-dependent relationship between Hashimoto thyroiditis and papillary thyroid carcinoma

Feng Zeng, Chuyu Liu, Yulan Cai
Frontiers in Immunology
Thyroid Cancer Diagnosis and Treatment
article

Immune-stromal-lymphatic communication shapes the context-dependent relationship between Hashimoto thyroiditis and papillary thyroid carcinoma

Feng Zeng, Chuyu Liu, Yulan Cai
article en

Abstract

Hashimoto thyroiditis (HT) and papillary thyroid carcinoma (PTC) frequently coexist, yet their clinical relationship remains paradoxical. Surgical and epidemiological series establish heterogeneous clinical associations: PTC is detected more often in some HT cohorts, whereas coexistent HT is associated with less aggressive disease in many outcome studies. Tissue studies separately establish organized autoimmune inflammation in HT and heterogeneous immune, stromal, endothelial, and lymphatic programs in PTC. What is not established is that these compartments form a single causal mechanism at the HT-PTC interface. The principal contribution of this review is therefore a hypothesis-generating, spatially explicit framework asking whether autoimmune tissue architecture that may predate tumor detection modifies subsequent tumor evolution. We distinguish distant autoimmune follicles from tumor-associated tertiary lymphoid structures (TLSs), and we separate direct HT-PTC observations from HT-only evidence, PTC evidence that is not HT-specific, and mechanistic extrapolation. The proposed framework integrates CCL21-CCR7 and CXCL13-CXCR5 signaling, ACKR1-positive endothelial entry sites, fibroblast states, TLS phenotype and location, and VEGF-C/VEGF-D-VEGFR3-associated lymphatic remodeling. These processes may have different relevance to tumor initiation and to progression after PTC is established. Depending on region, tumor genotype, immune function, stromal state, and tumor-lymphatic proximity, an inflamed gland may support epithelial injury, productive antitumor immunity, an inflamed but ineffective immune state, or lymphatic dissemination. These spatial features remain mechanistic and exploratory prognostic candidates; they are not validated diagnostic, predictive, or treatment-directing biomarkers. Region-matched human studies, functional perturbation, independent retrospective validation, and prospective clinical-utility testing are required.

Frontiers in ImmunologyVol. 17
Zunyi Medical University (CN), Affiliated Hospital of Zunyi Medical College (CN)
National Natural Science Foundation of China
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon